Full Product Name
IRF6 Antibody, HRP conjugated
Product Synonym Names
Interferon regulatory factor 6; IRF-6; IRF6
Product Gene Name
anti-IRF6 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for O14896
Purity/Purification
>95%, Protein G purified
Immunogen
Recombinant Human Interferon regulatory factor 6 protein (43-285AA)
Preservative
0.03% Proclin 300
Constituents
50% Glycerol, 0.01M PBS, pH 7.4
Santa Cruz Alternative
Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-130790 / sc-30451
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C or -80 degree C. Avoid repeated freeze.
ISO Certification
Manufactured in an ISO 13485:2003 and EN ISO 13485:2012 Certified Laboratory.
Other Notes
Small volumes of anti-IRF6 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-IRF6 antibody
Probable DNA-binding transcriptional activator. Key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development (By similarity). Plays a role in regulating mammary epithelial cell proliferation (By similarity). May regulate WDR65 transcription (By similarity).
Applications Tested/Suitable for anti-IRF6 antibody
ELISA (EIA)
NCBI/Uniprot data below describe general gene information for IRF6. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001193625.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001206696.1
[Other Products]
UniProt Primary Accession #
O14896
[Other Products]
UniProt Secondary Accession #
B4DLE2; D3DT90; F5GWX8; G0ZTL0[Other Products]
UniProt Related Accession #
O14896[Other Products]
Molecular Weight
41,930 Da
NCBI Official Full Name
interferon regulatory factor 6 isoform 2
NCBI Official Synonym Full Names
interferon regulatory factor 6
NCBI Official Symbol
IRF6 [Similar Products]
NCBI Official Synonym Symbols
LPS; PIT; PPS; VWS; OFC6; PPS1; VWS1
[Similar Products]
NCBI Protein Information
interferon regulatory factor 6
UniProt Protein Name
Interferon regulatory factor 6
Protein Family
Interferon regulatory factor
UniProt Gene Name
IRF6 [Similar Products]
UniProt Synonym Gene Names
IRF-6 [Similar Products]
UniProt Entry Name
IRF6_HUMAN
NCBI Summary for IRF6
This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2011]
UniProt Comments for IRF6
IRF6: Probable DNA-binding transcriptional activator. Key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development. Plays a role in regulating mammary epithelial cell proliferation. May regulate WDR65 transcription. Interacts with SERPINB5. Expressed in normal mammary epithelial cells. Expression is reduced or absent in breast carcinomas. Belongs to the IRF family.
Protein type: DNA-binding; Transcription factor
Chromosomal Location of Human Ortholog: 1q32.3-q41
Cellular Component: cytoplasm; cytosol
Molecular Function: DNA binding; protein binding; transcription factor activity
Biological Process: cell cycle arrest; negative regulation of cell proliferation; positive regulation of transcription, DNA-dependent
Disease: Orofacial Cleft 6, Susceptibility To; Popliteal Pterygium Syndrome; Van Der Woude Syndrome 1
Research Articles on IRF6
1. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndrome and contribute to nonsyndromic cleft lip phenotypes but have not previously been associated with a PRS phenotype.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.